Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Clifford Chance has hired Michael Welch as counsel in its US structured finance team. He joins the firm’s Washington, DC office from Chapman and Cutler. Sidley Austin elected 28 new partners....
...Mr Welch recognised early on that the open contest for his successor at GE would probably prompt the defeated managers to quit — and so it did. Likewise, at Pfizer both losers left....
...Related links: Shared mobility V.1, USSR edition – FT Alphaville Do the economics of self-driving taxis actually make sense? – FT Alphaville Who are Tesla’s competitors, really?...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...GMI Ratings identifies 21 chief executives who retired with more than $100m each since the start of the millennium, led by $417m for Jack Welch at GE....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...“Strengthening international diplomacy and co-operation between peoples” is what Jack Welch would call a “stretch target”. But it needs to be more specific....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...At General Electric, where he was vice-president of litigation and legal policy, he says that under Jack Welch, the former chief executive, “I saw the idea of a very large company with scale and resources...
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...With their companies in a state of transition, the freshly minted chief executives of food and drinks group PepsiCo and Pfizer, the drug maker, may not devote too much attention to the size of their mugshot...
...He had just lost out to Jeffrey Immelt in the battle to succeed Jack Welch as chief executive of General Electric. Six years later, the setback is starting to look like a stroke of luck....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition